INSIGHTS ON DRUG DEVELOPMENT

• Nose To Brain (N2B) Drug Delivery – Benefits And Challenges

  Delve into the growing interest in drug delivery methods that target the brain and central nervous system via absorption into the bloodstream, specifically focusing on crossing the blood-brain barrier (BBB).

• Advances In Custom Medium Development: The Multi-Omics Difference

  Spent media analysis continues to be an essential part of many media development workflows. Newer techniques, however, using state-of-the-art analytical technology, are becoming more popular.

• Evaluating On-Target/Off-Tumor Effects Of Cancer Immunotherapies

  A promising class of engineered T-cell engaging bispecific antibodies (TCBs) is revolutionizing cancer treatment, but safety concerns persist. Organs-on-Chips offer a human-relevant solution.

• Revolutionizing Viral Infectious Disease Research And Drug Discovery

  Learn how Organ-Chips are being used to rapidly identify promising treatments, investigate virus evolution, and analyze how mechanical forces influence the innate immune response to viral infections.

• API In Capsule Vs. The Lost Art Of Formulation Development

  11/5/2025

  API-in-capsule offers a fast path for early clinical data, but it can't eliminate the need for full formulation development. Weighing the potential for higher total development time and cost is critical.

• Microphysiological Systems: The Future Of Research And Drug Development

  2/14/2024

  Discover how microphysiological systems are revolutionizing the life sciences, offering a more accurate and reliable approach to studying human physiology and developing promising new drugs.

• Formulating Better ASDs And mAbs: Advances In Applied Nanotechnology

  5/1/2024

  Learn about new data on nanotechnology formulations for multiple dose forms and routes of delivery, including oral, long-acting injectables, inhalation, and ophthalmic.

• Strategies For The Development Of Safe And Effective Pediatric Formulations

  5/12/2025

  Medicines for infants and children face unique formulation challenges. Learn about the key considerations, including developmental physiology, age specifics, palatability, ease of administration, and precise dosing.

• Automating High-Throughput Screens Using Patient-Derived Organoids

  3/17/2025

  Many oncology drugs fail in later development stages due to inadequate predictive models. Explore how 3D cell models, like patient-derived organoids, offer a promising solution in the drug development process.